Saturday, November 6, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0252
Role of Clinical and Laboratory Parameters in Differentiating Infection from Disease Flare in Febrile Patients of Systemic Juvenile Idiopathic Arthritis
Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)- 8:30AM-10:30AM
-
Abstract Number: 0397
Safety and Persistence of Monthly Intravenous Iloprost in Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0187
Safety and Tolerability of Nintedanib in Patients with Autoimmune Disease-Related Interstitial Lung Diseases: Pooled Data from the SENSCIS and INBUILD Trials
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0100
Safety of COVID-19 Vaccines After First Vaccination in Patients with Rheumatic Diseases in a Patient Reported Survey
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0300
Salivary Gland Epithelial Cells Transcriptomic Analysis Highlight Their Potential Involvement in Extracellular Matrix Modification in Sjögren’s Syndrome
Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)- 8:30AM-10:30AM
-
Abstract Number: 0002
Salivary Sodium Levels in the Parotid Salivary Gland of SS Patients Suggest B-cell Mediated Epithelial Sodium Channel Disruption
B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster (0001–0010)- 8:30AM-10:30AM
-
Abstract Number: 0086
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0089
SARS-CoV-2 Seroprevalence and Seroconversion in a Systemic Lupus Erythematosus Cohort and Comparison to General Population Controls
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0373
Self-monitoring of Disease Activity with a Smartphone App Is Feasible in Routine Clinical Management of Patients with Axial Spondyloarthritis – a Proof of Concept Study
Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)- 8:30AM-10:30AM
-
Abstract Number: 0237
Self-perceived General Health at Start of Anti-TNF Therapy Predicts Therapeutic Response in Patients with Rheumatoid Arthritis: Analysis from the Czech Biologics Registry ATTRA
Patient Outcomes, Preferences, & Attitudes Poster I: Impact (0225–0240)- 8:30AM-10:30AM
-
Abstract Number: 0371
Self-referral Strategy for Early Diagnosis of Axial Spondyloarthritis- Preliminary Analysis from Finding Axial Spondyloarthritis Study
Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)- 8:30AM-10:30AM
-
Abstract Number: 0176
Semi-quantitative Chest Computed Tomography (CT) Analysis in Pediatric Rheumatologic (PR) Patients with Diffuse Lung Disease
Imaging of Rheumatic Diseases Poster (0149–0182)- 8:30AM-10:30AM
-
Abstract Number: 0321
Sequential Administration of Belimumab and Rituximab in Primary Sjögren’s Syndrome Reduces Minor Salivary Gland–Resident B Cells and Delays B-Cell Repopulation in Circulation
Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)- 8:30AM-10:30AM
-
Abstract Number: 0330
Serologic Phenotypes Distinguish SLE Patients with Myositis And/or Interstitial Lung Disease (ILD)